Jang (2022)
Major adverse cardiovascular events in diabetes
Cardiology • National_Database Data • South Korea
Study Metrics
Total Sample
23126
Treatment Group
11563
Control Group
11563
Covariates
72
PICO Comparisons
0
Quality Indicators
Transparency
High
DAG Usage
No
QBA Performed
No
Study Information
| First Author: | Jang |
| Publication Year: | 2022 |
| DOI: | https://doi.org/10.3389/fphar.2022.928121 |
| Preprint: | https://doi.org/10.21203/rs.3.rs-1362085/v1 |
Institution & Funding
| Institution Type: | Academic |
| Institutions: | Seoul National University |
| Funding: | Declared: Public |
| Funding Institutions: | This research was supported by a grant (20173MFDS171) from the Ministry of Food and Drug Safety in 2020. |
Study Context
| Disease: | Major adverse cardiovascular events in diabetes |
| Disease Category: | Cardiology |
| Data Type: | national_database |
| Number of Data Sources: | 1 |
| Geography: | South Korea |
| Eligible Sample: | 48545.0 |
Analytical Methods
| Missing Data Method: | 1:1 matching |
| Matching Method: | Cox PH, logistic regression |
| Analysis Method: | ITT |
Quality Methods
Directed Acyclic Graph (DAG)
Not Used
Quantitative Bias Analysis (QBA)
Not Performed
Target Trial Information
| Target Trial Name: | EMPA-REG OUTCOME |
| Registration Number: | NCT01131676 |
| Target Trial DOI: | https://doi.org/10.1056/NEJMoa1504720 |
Transparency Indicators
Protocol Registration
Available
Data Sharing
Not Available
Code Sharing
Not Available
Overall Transparency Score:
High Transparency - This study meets good transparency standards.
Conflicts & Funding
| Conflicts of Interest: | Declared: None |
| Funding Source: | Declared: Public |
| Funding Institutions: | This research was supported by a grant (20173MFDS171) from the Ministry of Food and Drug Safety in 2020. |